MedKoo Cat#: 534920 | Name: Sulfaclomide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Sulfaclomide is an anti-infective agents.

Chemical Structure

Sulfaclomide
Sulfaclomide
CAS#4015-18-3

Theoretical Analysis

MedKoo Cat#: 534920

Name: Sulfaclomide

CAS#: 4015-18-3

Chemical Formula: C12H13ClN4O2S

Exact Mass: 312.0448

Molecular Weight: 312.77

Elemental Analysis: C, 46.08; H, 4.19; Cl, 11.33; N, 17.91; O, 10.23; S, 10.25

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Sulfaclomide
IUPAC/Chemical Name
4-Amino-N-(5-chloro-2,6-dimethyl-4-pyrimidinyl)benzenesulfonamide
InChi Key
JQBLWVSZNZIWFC-UHFFFAOYSA-N
InChi Code
InChI=1S/C12H13ClN4O2S/c1-7-11(13)12(16-8(2)15-7)17-20(18,19)10-5-3-9(14)4-6-10/h3-6H,14H2,1-2H3,(H,15,16,17)
SMILES Code
O=S(C1=CC=C(N)C=C1)(NC2=NC(C)=NC(C)=C2Cl)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 312.77 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Traeger A, Stein G. Pharmacokinetics of sulfaclomide and sulfamerazine in patients with impaired renal function after first and after repeated application. Int J Clin Pharmacol Biopharm. 1977 Jul;15(7):315-20. PMID: 892948. 2: Peiker G, Traeger A, Nöschel H, Bonow A, Hertel U. Untersuchungen zur Kinetik von Sulfaclomid und der Einfluss der Sulfaclomidtherapie auf die p-Aminohippursäure-Clearance in der Schwángerschaft [Studies on the kinetics of sulfaclomide and the effect of sulfaclomide therapy on p-aminohippuric acid clearance in pregnancy]. Zentralbl Gynakol. 1975;97(10):612-8. German. PMID: 1189751. 3: Meyer FP, Walther H. Zur Pharmakokinetik von Sulfaclomid beim Menschen unter therapeutisch relevantne Aspekten [Pharmacokinetics of sulfaclomide in man under therapeutically relevant conditions]. Int J Clin Pharmacol Biopharm. 1977 Jul;15(7):340-5. German. PMID: 892952. 4: Oelssner W, Meyer FP, Funk KF. Bericht über die klinisch-therapeutische Prüfung des neuen Langzeit-Sulfanilamids Sulfaclomid bei akuten bakteriellen Infektionen [Report on the clinical therapeutic evaluation of the new long-term sulfanilamide sulfaclomide in acute bacterial infections]. Dtsch Gesundheitsw. 1969 Nov 6;24(45):2113-9. German. PMID: 5365251. 5: Bräunlich H, Splinter FK. Zur Pharmakokinetik von Sulfamerazin, Sulfamethoxypyridazin und Sulfaclomid bei jungen und erwachsenen Ratten [Pharmacokinetics of sulfamerazine, sulfamethoxypyridazine and sulfaclomide in young and adult rats]. Acta Biol Med Ger. 1974;32(2-3):235-47. German. PMID: 4423849. 6: Fleck C, Nguyen Trong T, Bräunlich H. Relation between renal and hepatic excretion of drugs. XII. Influence of dexamethasone, triiodothyronine, or phenobarbital on the elimination of sulfonamides in rats of different ages. Exp Pathol. 1989;36(1):43-52. PMID: 2731589. 7: Seidel K. Therapie des rheumatischen Fiebers [Therapy of rheumatic fever]. Z Gesamte Inn Med. 1977 Jul 15;32(14):347-51. German. PMID: 335683. 8: Knoll U, Kühnert M, Walther H. Untersuchungen zum Einfluss von Huminsäuren auf die Resorption von Sulfaclomid bei Laboratoriumsratten [Effect of humic acids on the resorption of sulfaclomide in laboratory rats]. Arch Exp Veterinarmed. 1985 May;39(3):350-4. German. PMID: 2932083. 9: Heise GW, Paul G. Klinische Untersuchungen mit dem Langzeitsulfonamid Sulfaclomid [Clinical studies with a delayed-action sulfonamide, Sulfaclomide]. Z Urol Nephrol. 1969;62(4):303-6. German. PMID: 5403763. 10: Bräunlich H, Splinter FK. Renale Ausscheidung von Langzeitsulfonamiden bei Flüssigkeitsbelastung und Anderung des pH-Wertes des Harns [Renal excretion of long term sulfonamides under fluid administration and modification of the urinary pH value]. Acta Biol Med Ger. 1976;35(6):793-8. German. PMID: 10708. 11: Storch R, Brünlich H. Stimulierung der renalen Ausscheidung von- Aminohippursäure durch wiederholte Zufuhr von Pharmaka bei jungen und erwachsenen Ratten [Stimulation of renal excretion of p-aminohippuric acid by repeated administration of drugs in young and adult rats]. Acta Biol Med Ger. 1975;34(9):1529-39. German. PMID: 1221741.